Multiply Labs

Multiply Labs

featured image of Revolutionary Partnership Automates Cell Therapy Manufacturing for Age-Related Diseases

Revolutionary Partnership Automates Cell Therapy Manufacturing for Age-Related Diseases

BIOT

🙌 Multiply Labs and Retro Biosciences partner to automate cell therapy manufacturing for age-related diseases, valued at $85 million. 🌍

featured image of Revolutionary Partnership Expands Cell Therapy Development

Revolutionary Partnership Expands Cell Therapy Development

BIOT

📰 Multiply Labs and Thermo Fisher join forces to revolutionize cell therapy production! 💼🔬 Accelerating development and commercialization for patients. 🏭